By Counterforce Health Team in Aldurazyme (laronidase) —

How to Get Aldurazyme (Laronidase) Covered by Blue Cross Blue Shield in Florida: Complete PA Guide and Appeals Process

Answer Box: Getting Aldurazyme Covered by Florida Blue

Aldurazyme (laronidase) is covered by Florida Blue Cross Blue Shield as a provider-administered specialty drug under the medical benefit, requiring prior authorization and confirmed MPS I diagnosis. The fastest path to approval: (1) Obtain genetic/enzymatic testing confirming MPS I with reduced alpha-L-iduronidase activity, (2) Have your specialist submit PA through Florida Blue's provider portal with complete medical records, and (3) Coordinate with an in-network specialty pharmacy like Accredo. If denied, you have 180 days to file an internal appeal and can request external review through Florida DFS within 4 months of final denial.

Table of Contents

Plan Types & Coverage Implications

Florida Blue operates as the Blue Cross Blue Shield plan for Florida, covering approximately 36% of the state's insured population. Your specific coverage for Aldurazyme depends on your plan type:

  • Commercial Plans (PPO/HMO): Aldurazyme covered under medical benefit with PA requirements
  • Medicare Advantage: Listed in formularies as "laronidase soln for iv infusion" with potential tier restrictions
  • Medicaid Plans: Coverage varies; check your specific managed care plan
  • Self-Funded Employer Plans: Follow ERISA rules; verify through your Summary Plan Description
Note: All Florida Blue plans require in-network providers for specialty drug administration to avoid higher out-of-network costs.

Formulary Status & Tier Placement

Aldurazyme appears on Florida Blue's Provider-Administered Specialty Pharmacy Drug List, indicating coverage under the medical benefit rather than pharmacy benefit. Key details:

Coverage Element Status Verification Source
Formulary Status Covered as specialty drug Florida Blue Medication Guide
Prior Authorization Required for all plans Provider-Administered Drug List
Step Therapy Not typically required No step therapy alternatives exist
Quantity Limits Based on FDA dosing (0.58 mg/kg weekly) Medical necessity review

No true alternatives exist for Aldurazyme, as it's the only FDA-approved enzyme replacement therapy for MPS I. Hematopoietic stem cell transplant is considered for severe cases but isn't a pharmaceutical alternative requiring step therapy.

Prior Authorization Requirements

Florida Blue requires comprehensive documentation for Aldurazyme PA approval:

Required Documentation

  • Confirmed MPS I diagnosis through genetic testing (biallelic IDUA mutations) OR enzymatic confirmation (alpha-L-iduronidase activity <10% of normal)
  • Clinical assessment documenting MPS I symptoms and severity
  • Treatment plan including dosing rationale, infusion site, and monitoring schedule
  • Prescriber attestation from genetics specialist or metabolic disease specialist

Diagnostic Requirements

Based on standard MPS I diagnostic criteria, Florida Blue typically requires:

  1. Enzymatic Testing: IDUA enzyme activity measurement in leukocytes, plasma, or dried blood spots
  2. Genetic Confirmation: IDUA gene sequencing showing biallelic pathogenic variants
  3. Clinical Documentation: Physical exam findings, imaging results, pulmonary function tests
Tip: Submit both enzymatic and genetic testing results when available, as some plans require both to rule out pseudodeficiency variants.

Specialty Pharmacy Network

Florida Blue partners with Prime Therapeutics for specialty pharmacy management. Aldurazyme must be obtained through:

  • In-Network Specialty Pharmacies: Accredo, CVS/Caremark Specialty, or other Prime-contracted pharmacies
  • Provider-Administered Settings: Physician offices, infusion centers, or home health services

Infusion Site Options

Setting Advantages Typical Costs Coordination Steps
Home Infusion Lower facility fees, convenience Medical deductible + coinsurance Specialty pharmacy coordinates with home health
Clinic/Office Direct physician oversight Medical deductible + coinsurance + facility fees Schedule through provider's infusion center
Hospital Outpatient Full medical support Highest cost due to facility fees Requires PA for outpatient setting

Step-by-Step Approval Process

1. Obtain Diagnostic Testing

Who: Patient with specialist referral
Timeline: 2-4 weeks for results
Required: Enzymatic IDUA testing and/or genetic sequencing

2. Specialist Evaluation

Who: Genetics specialist or metabolic disease specialist
Documentation: Complete clinical assessment, treatment plan, medical necessity letter

3. Prior Authorization Submission

Who: Prescribing physician or staff
Portal: Florida Blue Provider Portal or Availity
Timeline: Submit within 180 days of treatment need

4. Specialty Pharmacy Coordination

Who: Provider coordinates with patient
Process: PA approval triggers specialty pharmacy outreach for drug procurement and delivery

5. Infusion Setup

Who: Patient with specialty pharmacy and infusion provider
Timeline: 1-2 weeks after PA approval for first infusion

6. Ongoing Monitoring

Who: Prescribing specialist
Requirement: Regular assessments for continued medical necessity, typically every 6-12 months

Common Denial Reasons & Solutions

Denial Reason Solution Strategy Required Documentation
Insufficient diagnostic proof Submit complete enzymatic and genetic testing IDUA enzyme activity <10% normal, genetic sequencing results
Missing specialist evaluation Obtain genetics or metabolic specialist consultation Specialist assessment letter with treatment rationale
Incomplete prior therapy documentation Not applicable - no alternatives to step through Document any supportive therapies tried
Quantity/dosing concerns Justify FDA-approved dosing Reference FDA label: 0.58 mg/kg IV weekly
Site of care restrictions Request exception for preferred setting Medical necessity for home vs. clinic administration

Appeals Process in Florida

If Florida Blue denies your Aldurazyme PA, you have well-defined appeal rights under Florida law:

Internal Appeal (Level 1)

  • Deadline: 180 days from denial notice
  • Submission: Provider Clinical Appeal Form or member appeal form
  • Timeline: 30 days for standard review, 72 hours for expedited
  • Contact: 1-877-719-2583 for provider appeals

Peer-to-Peer Review

  • Availability: Before or during internal appeal
  • Process: Physician-to-physician discussion with Florida Blue medical director
  • Scheduling: Call 1-877-719-2583 within 72 hours of request

External Review (Independent)

  • Eligibility: After exhausting internal appeals
  • Deadline: 4 months from final internal denial
  • Process: Free review through Florida Department of Financial Services
  • Contact: 1-877-693-5236 (Insurance Consumer Helpline)
  • Timeline: 45 days standard, 72 hours expedited
Important: External review decisions are binding on Florida Blue and cannot be appealed further.

Cost-Share Dynamics

Aldurazyme costs under Florida Blue depend on your specific plan design:

Typical Cost Structure

  • Medical Deductible: Applied first (varies by plan)
  • Coinsurance: Usually 10-30% after deductible for specialty drugs
  • Out-of-Pocket Maximum: Annual limit provides cost protection

Financial Assistance Options

  • Sanofi CareConnect: Covers 100% of eligible out-of-pocket costs for commercial plans (not Medicare/Medicaid)
  • Contact: 1-800-745-4447, option 3
  • Eligibility: Income and insurance requirements apply
Note: With manufacturer list price around $1,113.38 per 2.9 mg vial, annual costs can exceed $50,000, making copay assistance crucial for many patients.

When to Escalate

Contact Florida regulators if you experience:

  • Unreasonable delays beyond standard timelines
  • Improper denial of medically necessary treatment
  • Procedural violations in the appeal process

Florida Department of Financial Services

  • Insurance Consumer Helpline: 1-877-693-5236
  • Online Complaints: MyFloridaCFO.com
  • Services: Complaint mediation, external review coordination, regulatory oversight

FAQ

How long does Florida Blue PA take for Aldurazyme?
Standard PA decisions typically take 30 days, but expedited reviews (with physician attestation of urgency) can be completed within 72 hours.

What if Aldurazyme isn't on my specific plan's formulary?
Request a formulary exception through the same PA process, emphasizing lack of therapeutic alternatives and medical necessity.

Can I get expedited appeals in Florida?
Yes, if your physician attests that delays could seriously jeopardize your health. Expedited internal appeals take 24-72 hours, external reviews take 72 hours.

Does step therapy apply if I've tried treatments in another state?
Document all prior therapies with medical records. Florida Blue should recognize out-of-state treatment failures if properly documented.

What happens if I move between Florida Blue plans?
PA approvals may need renewal. Contact member services immediately to ensure continuity of coverage.

Who can prescribe Aldurazyme in Florida?
Typically genetics specialists, metabolic disease specialists, or physicians with experience treating lysosomal storage disorders.

At Counterforce Health, we help patients and clinicians navigate complex prior authorization processes for specialty medications like Aldurazyme. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed appeals that turn insurance denials into approvals. By understanding each payer's specific requirements and building comprehensive medical necessity cases, we help ensure patients get access to the treatments they need.

For comprehensive support with your Aldurazyme appeal, visit Counterforce Health to learn how our platform can help build your strongest case for coverage.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and requirements change frequently. Always verify current information with Florida Blue directly and consult with your healthcare provider for medical decisions. For insurance complaints or assistance with appeals, contact the Florida Department of Financial Services at 1-877-693-5236.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.